太原怎么治疗外痔(山西痔疮最快速消肿) (今日更新中)

BERLIN, June 6 (Xinhua) -- The German authorities said on Monday that Germany's first sample tests of the allegedly contaminated bean sprouts have found no E. coli strains that have sickened more than 2,000 people in Europe.According to a statement issued by the Agriculture Ministry of the Lower-Saxony state, 23 of 40 samples concerning the suspected sprouts from a market garden in the state have tested negative, and further tests are still pending."Based on the initial findings in tests of some of the samples, especially the seeds, we assume that intensive analytical efforts are needed to prove that the suspected pathogen is really there," the statement said.Beansprouts and salad sprouts are seen in this picture illustration taken in Berlin June 6, 2011.  The German authorities said on Monday that Germany's first sample tests of the allegedly contaminated bean sprouts have found no E. coli strains that have sickened more than 2,000 people in EuropeLower-Saxony's Agriculture Minister Gert Lindemann said Sunday that a market garden in the rural district of Uelzen had provided a connection "involving all the main outbreaks" of the disease.Restaurants and food outlets of almost all E. coli-affected areas had received shipments of sprouts directly or indirectly from the company, state officials said.The German authorities have been racing to track down the source of the pathogen since the outbreak, which has infected people in 12 countries, all of whom had once traveled in northern Germany.More than 600 of those infected have developed Hemolytic Uremic Syndrome, a potentially deadly complication attacking the kidneys.The E. coli source was first thought to be cucumbers from Spain, which has caused huge loses for Spain farmers. However, this conclusion was overthrown by laboratory tests in Hamburg later.

LOS ANGELES, June 5 (Xinhua) -- A latest study has found no evidence that screening for ovarian cancer may reduce the risk of dying from the disease, it was reported on Sunday.Screening, however, does increase the likelihood of unnecessary invasive procedures, according to researchers at the University of Utah.The researchers presented their findings at an on-going meeting of the American Society of Clinical Oncology in Chicago, The Los Angeles Times said.Researchers studied 78,216 women, ages 55 to 74, who participated in the National Cancer Institute's Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Half of the women received the usual care from their OB-gyns, and half received a CA 125 screening every year for six years and an ultrasound every year for four years. They were then followed for a maximum of 12 years.The researchers observed 212 ovarian cancers in the screened group and 176 in the normal care group. There were 118 ovarian cancer deaths in the screened group and 100 in the normal care group. The differences were not statistically significant. Overall, there were 2,924 deaths from all causes in the screened group and 2,914 in the normal care group.But the researchers also observed that 3,285 women had false- positive diagnoses from the screening. Among those, 1,080 underwent surgery that included an oophorectomy (surgical removal of one or both ovaries). Fifteen percent of those who had surgery developed major complications as a result. Overall, 1,771 women in the screened group (7.7 percent) had an oophorectomy, compared with 1,304 in the normal care group (5.8 percent)."We conclude that annual screening for ovarian cancer ... does not reduce disease-specific mortality in women at average risk for ovarian cancer but does increase invasive medical procedures and associated harms," the researchers said in the study.New data presented at the meeting also showed that the widely used cancer drug Avastin can improve treatment of ovarian cancer, The Times said.About 21,880 American women are diagnosed with ovarian cancer each year and about 13,850 die from it, according to the American Cancer Society. Because it produces few symptoms, the disease is typically not diagnosed until it has become advanced and spread throughout the body. As a result, five-year survival is only about 30 percent, and the disease is one of the five most deadly cancers among women. Being able to detect the cancer at an earlier stage when it might be more curable could thus, theoretically, improve the survival rate.The tests most commonly used to detect ovarian cancer include a transvaginal ultrasound to look for tumor masses and a blood test that screens for increased levels of a tumor marker called CA 125.

SINGAPORE, Sept. 7 (Xinhua) -- Singapore scientists have found possible new ways to treat a type of aggressive breast cancer that is unresponsive to current forms of treatment, local broadcaster Channel NewsAsia reported on Wednesday.The team of scientists at the Genome Institute of Singapore ( GIS) and National University of Singapore (NUS), led by GIS senior group leader Qiang Yu, found that the enzyme EZH2 acts by inhibiting genes that stop the growth of tumors in the body.The insights could open the door to developing more effective treatment for fast spreading breast cancers, especially the estrogen receptor-negative breast cancer that is common all over the world.It was also found that through EZH2, cancer is promoted in the body by activating specific genes that impact breast cancer progression and cancer stem cell self-renewal.Yu said the new understanding on how EZH2 works as a cancer- causing gene in breast cancer has important therapeutic implication."The results suggest that small molecule drugs that block enzyme activity of EZH2 may not work for cancers caused by EZH2's activation genes," Yu said.Currently pharmaceutical companies have been developing drugs only to the block EZH2 enzyme activity so that tumor suppressers can perform their protective role in blocking cancer growth.Researchers said the next step would be to develop biomarkers to identify tumors with EZH2.This step would enable better treatment methods, with one of options being the development of therapies that shut down EZH2 completely and not just inhibit its enzymatic function.The findings have been published on the journal Molecular Cell.

SYDNEY, June 29 (Xinhua) -- A type of dried seaweed sold in Asian food supermarkets in Australia has been recalled after it was found to have high levels of iodine dangerous to pregnant women, local media reported on Wednesday.Food Standards Australia New Zealand (FSANZ) has ordered the recall of Wang Dried Kelp Varech Speche, a Korean brand of the dried seaweed, according to Australian Associated Press (AAP).It has been available in Asian grocery stores and restaurants in the Brisbane and Gold Coast areas of Queensland."The product contains high levels of naturally occurring iodine," FSANZ said in a statement."Regular consumption of these products may cause health problems in some people including pregnant and breastfeeding women."FSANZ said consumers concerned about their health should seek medical advice and should return the products to the place of purchase for a full cash refund.

WASHINGTON, June 21 (Xinhua) -- Brain cancer patients who are able to exercise live significantly longer than sedentary patients, U.S. scientists at the Duke Cancer Institute have reported.The finding, published online this week in the Journal of Clinical Oncology, adds to recent research that exercise improves how cancer patients feel during and after treatments, and may also extend their lives.The study enrolled 243 patients with advanced recurrent gliomas, lethal brain malignancies that typically result in a median life expectancy of less than six months. The patients who reported participating in regular, brisk exercise -- the equivalent of an energetic walk five days a week for 30 minutes -- had significantly prolonged survival, living a median 21.84 months versus 13.03 months for the most sedentary patients."This provides some initial evidence that we need to look at the effects of exercise interventions, not only to ease symptoms but also to impact progression and survival," said Lee Jones, associate professor in the Duke Cancer Institute and senior author of the study.

来源：资阳报